Page last updated: 2024-10-29

iohexol and Ehlers-Danlos Syndrome

iohexol has been researched along with Ehlers-Danlos Syndrome in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Ehlers-Danlos Syndrome: A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chu, LC1
Johnson, PT1
Dietz, HC1
Brooke, BS1
Arnaoutakis, GJ1
Black, JH1
Fishman, EK1

Other Studies

1 other study available for iohexol and Ehlers-Danlos Syndrome

ArticleYear
Vascular complications of Ehlers-Danlos syndrome: CT findings.
    AJR. American journal of roentgenology, 2012, Volume: 198, Issue:2

    Topics: Adolescent; Adult; Angiography; Angiography, Digital Subtraction; Contrast Media; Ehlers-Danlos Synd

2012